脑胶质细胞瘤患者IL-6的表达及细胞免疫功能的变化

目的　研究脑胶质细胞瘤患者外周血中白细胞介素 6 (IL 6 )的含量、红细胞免疫功能和T淋巴细胞亚群的变化规律 ,探讨它们之间的相互关系及临床意义。方法　采用酶联免疫吸附 (ELISA)法测定患者IL 6的含量 ;免疫黏附法测定红细胞免疫活性及其调节功能 ;链亲和素 过氧化物酶 (S P)一步法测定CD3、CD4、CD8的细胞数。结果　脑胶质细胞瘤组IL 6含量较对照组明显降低 (P <0 .0 5 ) ;红细胞C3b受体 (RBC .C3bR)、红细胞免疫调节促进因子(RFER)亦明显降低 (P <0 .0 0 1) ,而红细胞免疫复合物 (RBC .ICR)、红细胞免疫调节抑制因子 (RFIR)则明显升高 ;CD3、CD4细胞数明显降低 (P <0 .0 1) ,而CD8无明显差异 (P >0 .0 5 )。结论　脑胶质细胞瘤患者出现免疫功能低下 ,检测患者IL 6含量、红细胞免疫功能及T细胞亚群活性在脑胶质细胞瘤的发生、发展、治疗、转归及预后方面具有重要的临床指导意义。

Study on alteration of IL-6 and cell immunity in patients with cerebral glioma

Objective To study the content of interleukin- 6 (IL-6) and the altering pattern of erythrocyte immunity and T cell subgroup in the blood of outer circulation in the patients with cerebral glioma, and to expl ore their relationship and the clinical significance. Methods Enzyme linked immunosorbent assay (ELISA) was used to determine the content o f IL-6. The immunoabsorption was employed to examine the erythrocytic immune ac tivity and its regulatory function. Streptavidin-Peroxidase (S-P) was used to determine the cell number of CD3 (cluster of differentiation 3), CD4, CD8. Results The content of IL-6 in the group with cerebral glioma i s significantly lower than that in the control group (P<0.05). Red blood cel l C3b receptor(RBC.C3bR) and RBC immune adherence enhance factor (RFER) dropped greatly (P<0.001), while red blood cell immune complex rosstte (RBC.ICR) and RBC immune adherence inhibitor factor (RFIR) increased greatly. The cell number of CD3, CD4 dropped (P<0.01) and there was no evident change for CD8 (P >0.05). Conclusion The weakening of immune function is obse rved in the patients with cerebral glioma. Testing of the content of IL-6, eryt hrocyte immunity and the activity of T subgroup has important clinical significa nce in the occurrence, development, treatment, outcome and prognosis of the cere bral glioma.